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Summary
Introduction: Any organ in the human body may be affected by hydatid disease, but the liver and
the lungs are most commonly affected. A rare localization of hydatid disease is within muscle
tissue. Herein we present three patients with muscular hydatid disease who were successfully
treated with a modified percutaneous approach.
Methods: Patients with Gharbi type III cysts were treated on an outpatient basis. All procedures
were performed under ultrasound guidance in the ultrasonography unit of our department. After
local anesthesia, percutaneous puncture was performed in a one-step procedure. After free
drainage stopped, absolute ethanol and polidocanol were injected into the cyst cavity. After the
procedure, the patient was observed for at least six hours for any adverse reactions and sent
home. Patients were followed-up with ultrasonography. A positive treatment effect was char-
acterized by a reduction of the cyst’s pseudo-tumor pattern and size, and by detachment of the
germinal membrane.
Results: The three patients in this report had a total of five hydatid cysts in muscle tissue and
were all successfully treated with a modified percutaneous approach without recurrence.
Conclusion: Percutaneous drainage without re-aspiration is simple, easy to apply, low cost,
repeatable, and does not require hospitalization. There have been no reported deaths associated
with the procedure and morbidity is very low. When the technique is applied properly, relapses do
not occur. With its low complication rate and its suitability for outpatient treatment, this method
can be an alternative to surgery or puncture, aspiration, injection, and re-aspiration (PAIR) in
selected patients.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +90 312 231 17 95; fax: +90 312 419 50 79.
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Ecchinococcosis or hydatid disease, a parasitic infection
caused by Echinococcus granulosus or Echinococcus multi-
locularis, is prevalent in most sheep- and cattle-raising
countries in the Mediterranean region and the Middle East,
as well as Asia, Australia, New Zealand, and South America.
The disease is still an important cause of morbidity in these
parts of the world.1 Most cases of hydatid disease are gen-
erally asymptomatic, and when apparent the symptoms are
due to compression of adjacent structures by enlarging
cysts.
Largely occurring in the liver and lungs, musculoskeletal
involvement is a raremanifestation of hydatid disease due to
the high lactic acid concentration in skeletal muscle and to
mechanical factors such as contractile activity,2 and usually
affects a single muscle. Ultrasonography, computerized
tomography (CT), and magnetic resonance imaging (MRI)
are useful in the diagnosis and classification of the
cysts.3—8 Current methods of treatment include surgery,
percutaneous methods like puncture, aspiration, injection,
and re-aspiration (PAIR), percutaneous drainage without re-
aspiration, and medical management with benzimidazole
derivatives.9—11 These methods are used principally for liver
cysts.
To our knowledge, there have been no published studies of
percutaneous aspiration for themanagement of muscle hyda-
tidosis. Herein we present three patients with hydatid cysts
in muscle tissue and their successful treatment with a mod-
ified percutaneous technique.
Methods
Intervention
Patients with muscle hydatidosis were classified according to
the Gharbi classification (Table 1).12 Those with Gharbi type
III cysts were treated on an outpatient basis. All procedures
were performed under ultrasound guidance in the ultrasono-
graphy unit of our department, which is fully equipped for
emergencies. An intravenous line was established and 50 mg
of meperidine was given 20 minutes before the procedure.
After local anesthesia, the percutaneous puncture was per-
formed with a 22-gauge Chiba needle in a one-step proce-
dure.
Unlike the PAIR technique, which includes re-aspiration
of the sclerosing agent used, this method involves punctur-
ing the cyst and allowing it to drain freely under its own
pressure.11 After free drainage has stopped, 2 mL of abso-
lute (96%) ethanol and 1 mL of polidocanol (aethoxysclerolTable 1 The Gharbi classification for hydatid cysts
Type I Purely cystic lesion
Type II Germinative membrane is detached within
parts of the cyst
Type III Multicystic lesion separated by septae
Type IV The cyst is degenerated with a pseudo-solid
appearance
Type V The pseudo-solid cyst and ectocyst are calcified1%) for each centimeter of the cyst’s longest diameter are
injected into the cyst cavity under ultrasound guidance. An
advantage of this technique is that type III cysts can also be
treated, but without free drainage. The needle is then held
in place for five minutes within its sheath and is then with-
drawn from the patient. The alcohol mixture remains in the
cyst. After the procedure, the patient is observed for at least
six hours for any adverse reactions, and is then permitted to
go home.
Follow-up
Patients were followed-up with ultrasonography on the day
after the procedure (within 24 hours), twice in the first six
months and then every six months thereafter. A positive
treatment effect was characterized by a reduction of the
cyst’s pseudo-tumor pattern and size, and by detachment of
the germinal membrane. For each patient, CT examinations
were performed before treatment and at least six months
after.
Case reports
Case 1
A 51-year-old man presented to the Gastroenterology Unit
in June 1997 with pain and a palpable mass in the right
gastrocnemius muscle. His medical history was not signifi-
cant and his physical examination was unremarkable except
for the leg mass. All routine laboratory tests were normal.
On CT, two adjacent Gharbi type III cysts (multicystic fluid
collections with septae) with diameters of 10 cm each were
visible in the right gastrocnemius muscle (Figure 1A). Indir-
ect hemagglutination testing was positive for E. granulosus
at a titer of 1:800. After percutaneous treatment, the
hydatid cysts gradually became solid (Gharbi type IV)
(Figure 1B) and the pain in the muscle resolved. The patient
was followed up for almost eight years with ultrasonography
and CT.
Case 2
A 31-year-old man with chronic renal failure was hospitalized
in May 2000 with complaints of abdominal discomfort, nau-
sea, and muscle pain in the left upper leg. The patient had
undergone nine surgical operations, starting in 1994, for
recurrences of hydatid disease in this leg. On physical exam-
ination a painful and palpable mass was detected. Routine
biochemical tests revealed anemia, and elevated blood urea
nitrogen and creatinine levels. Ultrasonography and CT
revealed two Gharbi type III cysts in the left gluteus medius,
with maximal diameters of 5.6 and 4.8 cm, respectively
(Figure 2). In the gluteus maximus and iliopsoas muscles,
additional cysts smaller than 5 cm (1.5  1.5 cm, 4  3.5 cm,
2  2 cm, and 4  5 cm) were detected behind the two larger
lesions. The indirect hemagglutination test was positive
(>1:200) for E. granulosus. The two large cysts were success-
fully treated with a modified percutaneous method, and the
pain subsided and the palpable mass became smaller. Five
years after the procedure, ultrasonography and CTconfirmed
that the two cysts treated percutaneously had become solid
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Figure 1 (A) Prior to percutaneous sclerosing therapy, two
cysts are seen in the right gastrocnemius muscle with daughter
cysts (Gharbi type III). (B) Computerized tomography scan eight
years after therapy; the daughter cysts have disappeared in the
cyst located posteriorly while the cyst located anteriorly has
shrunk.
Figure 2 (A) Prior to percutaneous sclerosing therapy, two
hydatid lesions with daughter cysts were visualized by computed
tomography (CT) in the right gastrocnemius muscle. (B) Eight
years after treatment, the daughter cysts have disappeared or
diminished in size.(Gharbi type IV). There was no recurrence. The other cysts
had increased in diameter and further therapy was deferred
pending the development of symptoms and/or the cyst sizes
becoming large enough to puncture.
Case 3
A 45-year-old man presented to the hospital in February
2003 with the complaint of pain in the left gluteal area. He
had previously undergone surgery in September 2002 for a
6  3 cm hydatid cyst in the gluteus maximus muscle.
An MRI scan performed at that time revealed a Gharbi
type III muscle cyst (Figure 3), which was resected and
found to be hydatid on histopathologic examination. After
one year, the patient began having muscle pain. Ultrasound
revealed a Gharbi type I hydatid cyst measuring1.8  3 cm. On CT, the cyst was visible between the
gluteus maximus and gluteus medius muscles, and serum
levels of muscle enzymes were normal. In October 2003,
the cyst was treated with a modified percutaneous
method; immediately after the intervention the germina-
tive membrane was found to be detached from the peri-
cyst. The patient’s pain subsided, and during 24 months of
follow-up the cyst gradually solidified. There has been no
relapse.
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Figure 3 Multilocular cystic lesion in the gluteus maximus
muscle seen on CT scan.Discussion
The liver and lungs act as natural mechanical filters for
oncospheres following penetration of intestinal mucosa, thus
making it quite difficult for them to reach musculoskeletal
tissue. The proportion of hydatid disease localized in muscle
has been reported at 3—5%, occurring in various anatomic
regions including the thigh,2 quadriceps femoris,13 biceps
femoris,14 psoas,15 diaphragm,16 triceps,16 myocardium,17
right ventricular outlet,18 and extra-ocular muscles.19 It is
believed that local production of lactic acid and mechanical
factors such as contractile activity tend to inhibit the embryo
from settling in muscle.2,20 The three patients reported here
fulfilled the criteria for muscular hydatidosis with impair-
ment of muscle function and exclusion of liver and lung
involvement.21,22
Medical treatment with benzimidazole compounds
(mebendazole and albendazole) has been used in the man-
agement of liver and lung hydatid disease since the early
1970s. Their effects include prevention of the entrance of
tubulin into mitochondria, inhibition of glucose uptake with
suppression of glycogen deposits in the cyst, and disruption
of cyst homeostasis via reduced production of adenosine
triphosphate.23 Intracystic concentrations of mebendazole
may be only about 10% of the serum level. For this reason,
the drug’s effect is limited and approximately 3—30% of
cases recur after treatment is stopped.24 Consequently,
benzimidazole compounds cannot be used effectively in
muscle or kidney hydatid disease due to their low cystic
fluid concentrations.3,24,25 Also, according to an evidence-
based meta-analysis, combination treatment with albenda-
zole and praziquantel was found to be superior to albenda-
zole monotherapy.26 Thursky and Torresi successfully
treated a patient who was at high risk for dissemination
during the initial exploratory procedure with muscle resec-
tion and combination therapy with albendazole plus prazi-
quantel.2Surgery is the preferred therapeutic modality for muscu-
lar hydatid disease. However, disease recurrences are fre-
quent following surgical management. Repetitive surgical
operations and accompanying disorders increase postopera-
tive mortality from 0.9% to 3.5%.1,3,27
In 1985, the era of non-operative percutaneous treatment
of hepatic hydatid cysts began when Mueller and colleagues
demonstrated that administration of nitrate compounds and
hypertonic serum into the cyst cavity after aspiration of fluid
was not dangerous.28 In a study by Khuroo et al., percutaneous
treatment of liver cysts combinedwith albendazolewas super-
ior to surgical cystectomy in terms of hospital stay (4.2 vs. 12.7
days) and complication rate (32% vs. 84%).29 Similarly, a meta-
analysis of 21 trials comparing PAIR plus chemotherapy to
surgery concluded that overall cure rate, recurrence, inci-
dence of complications, fever, allergic reactions, and hospital
stay were significantly less in the former group.30
Percutaneous drainage without re-aspiration is simple,
easy to apply, low cost, repeatable, and does not require
hospitalization. There have been no reported deaths asso-
ciated with the procedure and morbidity is very low. When
the technique is applied properly, relapses do not occur. The
method has been used for hydatid cysts located in the spleen
and kidneys.31,32 The three patients in this report had a total
of five hydatid cysts in muscle tissue and were all successfully
treated with a modified percutaneous approach without
recurrence. Patient 2 had previously undergone nine unsa-
tisfactory surgical procedures for his muscle cysts.
In conclusion, percutaneous drainage without re-aspira-
tion of injected scolicide is a simple, effective, safe, repea-
table, and cheap modality for the management of muscle
hydatid disease. With its low complication rate and its suit-
ability for outpatient treatment, this method can be an
alternative to surgery or PAIR in selected patients.
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